|
1
|
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
|
Ann Neurol
|
2010
|
3.49
|
|
2
|
Visualizing out-of-body experience in the brain.
|
N Engl J Med
|
2007
|
2.44
|
|
3
|
Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas.
|
Epilepsia
|
2005
|
2.43
|
|
4
|
Optimized in vivo detection of dopamine release using 18F-fallypride PET.
|
J Nucl Med
|
2012
|
2.18
|
|
5
|
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
|
Eur J Nucl Med Mol Imaging
|
2010
|
2.09
|
|
6
|
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
|
Cell Metab
|
2008
|
1.94
|
|
7
|
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
|
Proc Natl Acad Sci U S A
|
2007
|
1.73
|
|
8
|
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
|
J Nucl Med
|
2009
|
1.70
|
|
9
|
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.
|
J Nucl Med
|
2009
|
1.65
|
|
10
|
Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat.
|
Exp Neurol
|
2007
|
1.55
|
|
11
|
Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy.
|
Exp Neurol
|
2009
|
1.52
|
|
12
|
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.49
|
|
13
|
Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.
|
Biol Psychiatry
|
2011
|
1.48
|
|
14
|
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.
|
Neuroimage
|
2013
|
1.48
|
|
15
|
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
|
Brain
|
2008
|
1.41
|
|
16
|
The use of SPECT and PET in routine clinical practice in epilepsy.
|
Curr Opin Neurol
|
2007
|
1.41
|
|
17
|
Automated quantitative gait analysis in animal models of movement disorders.
|
BMC Neurosci
|
2010
|
1.31
|
|
18
|
Quantification of Parkinson's disease-related network expression with ECD SPECT.
|
Eur J Nucl Med Mol Imaging
|
2006
|
1.24
|
|
19
|
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2012
|
1.21
|
|
20
|
Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET.
|
Neuroimage
|
2004
|
1.21
|
|
21
|
Evaluation of three MRI-based anatomical priors for quantitative PET brain imaging.
|
IEEE Trans Med Imaging
|
2011
|
1.20
|
|
22
|
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.
|
Eur J Nucl Med Mol Imaging
|
2012
|
1.19
|
|
23
|
Neuronuclear assessment of patients with epilepsy.
|
Semin Nucl Med
|
2008
|
1.17
|
|
24
|
Effects of MRI contrast agents on the stem cell phenotype.
|
Cell Transplant
|
2010
|
1.13
|
|
25
|
Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation.
|
EMBO Mol Med
|
2011
|
1.11
|
|
26
|
Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
|
J Nucl Med
|
2006
|
1.10
|
|
27
|
Abeta amyloid deposition in the language system and how the brain responds.
|
Brain
|
2007
|
1.05
|
|
28
|
Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [¹⁸F]fallypride.
|
Neuroimage
|
2011
|
1.04
|
|
29
|
Autoimmune-mediated encephalitis.
|
Neuroradiology
|
2011
|
1.01
|
|
30
|
Measuring extrastriatal dopamine release during a reward learning task.
|
Hum Brain Mapp
|
2011
|
1.01
|
|
31
|
Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: implications for the noninvasive delineation of the epileptogenic zone.
|
Epilepsia
|
2006
|
1.00
|
|
32
|
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.
|
PLoS One
|
2013
|
0.98
|
|
33
|
Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study.
|
Am J Gastroenterol
|
2010
|
0.96
|
|
34
|
Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies.
|
J Psychiatr Res
|
2009
|
0.96
|
|
35
|
Kinetic analysis of the cannabinoid-1 receptor PET tracer [(18)F]MK-9470 in human brain.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.96
|
|
36
|
Neurodegenerative Parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation.
|
Mov Disord
|
2009
|
0.95
|
|
37
|
Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
|
J Nucl Med
|
2010
|
0.95
|
|
38
|
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.93
|
|
39
|
COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge.
|
PLoS One
|
2013
|
0.93
|
|
40
|
Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.93
|
|
41
|
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity.
|
J Nucl Med
|
2013
|
0.91
|
|
42
|
Construction and evaluation of quantitative small-animal PET probabilistic atlases for [¹⁸F]FDG and [¹⁸F]FECT functional mapping of the mouse brain.
|
PLoS One
|
2013
|
0.90
|
|
43
|
Micro-positron emission tomography imaging of rat brain metabolism during expression of contextual conditioning.
|
J Neurosci
|
2012
|
0.90
|
|
44
|
Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
|
NMR Biomed
|
2009
|
0.90
|
|
45
|
Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
|
Nucl Med Biol
|
2009
|
0.90
|
|
46
|
In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.
|
J Pharmacol Exp Ther
|
2013
|
0.90
|
|
47
|
Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.
|
Seizure
|
2008
|
0.89
|
|
48
|
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.89
|
|
49
|
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
|
Neuroimage
|
2012
|
0.89
|
|
50
|
Whole-body biodistribution and radiation dosimetry of the cannabinoid type 2 receptor ligand [11C]-NE40 in healthy subjects.
|
Mol Imaging Biol
|
2013
|
0.88
|
|
51
|
Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence.
|
J Neurosci
|
2014
|
0.88
|
|
52
|
Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.
|
Curr Pharm Des
|
2008
|
0.88
|
|
53
|
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.
|
Nucl Med Biol
|
2011
|
0.87
|
|
54
|
Cognitive deficits during status epilepticus and time course of recovery: a case report.
|
Epilepsia
|
2007
|
0.87
|
|
55
|
A PET brain reporter gene system based on type 2 cannabinoid receptors.
|
J Nucl Med
|
2011
|
0.87
|
|
56
|
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.
|
Brain
|
2011
|
0.86
|
|
57
|
Face-selective hyper-animacy and hyper-familiarity misperception in a patient with moderate Alzheimer's disease.
|
J Neuropsychiatry Clin Neurosci
|
2013
|
0.86
|
|
58
|
Small animal positron emission tomography during vagus nerve stimulation in rats: a pilot study.
|
Epilepsy Res
|
2005
|
0.86
|
|
59
|
Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
|
Nucl Med Biol
|
2008
|
0.85
|
|
60
|
In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.85
|
|
61
|
Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression.
|
Neurobiol Aging
|
2006
|
0.85
|
|
62
|
Regional brain activity in functional dyspepsia: a H(2)(15)O-PET study on the role of gastric sensitivity and abuse history.
|
Gastroenterology
|
2010
|
0.85
|
|
63
|
Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
|
Neuroimage
|
2012
|
0.85
|
|
64
|
Characterization of the inflammatory response in a photothrombotic stroke model by MRI: implications for stem cell transplantation.
|
Mol Imaging Biol
|
2011
|
0.84
|
|
65
|
Neurostimulation for refractory epilepsy.
|
Acta Neurol Belg
|
2003
|
0.84
|
|
66
|
99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.84
|
|
67
|
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.84
|
|
68
|
[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
|
Addict Biol
|
2013
|
0.84
|
|
69
|
Images in neurology. Scattered cerebral microbleeds due to cardiac myxoma.
|
Arch Neurol
|
2009
|
0.84
|
|
70
|
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.83
|
|
71
|
99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine.
|
Nucl Med Commun
|
2004
|
0.83
|
|
72
|
PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
|
Neurology
|
2013
|
0.83
|
|
73
|
Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.
|
Bioorg Med Chem
|
2011
|
0.83
|
|
74
|
Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.
|
Nucl Med Biol
|
2007
|
0.82
|
|
75
|
Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex.
|
Schizophr Bull
|
2013
|
0.82
|
|
76
|
Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
|
J Nucl Med
|
2003
|
0.81
|
|
77
|
Synthesis and biological evaluation of [¹¹C]SB366791: a new PET-radioligand for in vivo imaging of the TRPV1 receptor.
|
Nucl Med Biol
|
2012
|
0.81
|
|
78
|
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
|
Neuroimage Clin
|
2013
|
0.81
|
|
79
|
Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects.
|
Psychopharmacology (Berl)
|
2009
|
0.81
|
|
80
|
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.80
|
|
81
|
A strange face in the mirror. Face-selective self-misidentification in a patient with right lateralized occipito-temporal hypo-metabolism.
|
Cortex
|
2012
|
0.80
|
|
82
|
Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.
|
MAGMA
|
2010
|
0.80
|
|
83
|
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
|
Brain Res
|
2009
|
0.80
|
|
84
|
Characterization of the novel GlyT1 PET tracer [18F]MK-6577 in humans.
|
Synapse
|
2014
|
0.80
|
|
85
|
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.80
|
|
86
|
Long term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain.
|
Surg Neurol
|
2009
|
0.79
|
|
87
|
Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease.
|
J Med Chem
|
2009
|
0.79
|
|
88
|
Influence of chronic nicotine administration on cerebral type 1 cannabinoid receptor binding: an in vivo micro-PET study in the rat using [18F]MK-9470.
|
J Mol Neurosci
|
2010
|
0.79
|
|
89
|
Radiolabeling strategies for radionuclide imaging of stem cells.
|
Stem Cell Rev
|
2015
|
0.79
|
|
90
|
Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.79
|
|
91
|
Metabolic evidence for episodic memory plasticity in the nonepileptic temporal lobe of patients with mesial temporal epilepsy.
|
Epilepsia
|
2011
|
0.79
|
|
92
|
Age and gender effects on normal regional cerebral blood flow.
|
AJNR Am J Neuroradiol
|
2006
|
0.78
|
|
93
|
The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.78
|
|
94
|
An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
|
Neuropharmacology
|
2008
|
0.78
|
|
95
|
Paradoxical interictal cerebral cortical hypermetabolism on brain FDG PET in Sturge-Weber syndrome.
|
Clin Nucl Med
|
2011
|
0.78
|
|
96
|
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
|
Synapse
|
2010
|
0.78
|
|
97
|
Quantitative PET imaging of radioligands with slow kinetics in human brain.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.78
|
|
98
|
Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
|
J Nucl Med
|
2016
|
0.78
|
|
99
|
Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.78
|
|
100
|
Interictal type 1 cannabinoid receptor binding is increased in female migraine patients.
|
Headache
|
2011
|
0.78
|
|
101
|
Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: a [F]MK-9470 PET study.
|
Psychother Psychosom
|
2015
|
0.78
|
|
102
|
Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.78
|
|
103
|
Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.78
|
|
104
|
Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.77
|
|
105
|
The interest of amyloid PET imaging in the diagnosis of Alzheimer's disease.
|
Curr Opin Neurol
|
2013
|
0.77
|
|
106
|
Motor- and food-related metabolic cerebral changes in the activity-based rat model for anorexia nervosa: a voxel-based microPET study.
|
Neuroimage
|
2006
|
0.77
|
|
107
|
Reply: Task- versus amphetamine-induced displacement of high-affinity D2/3 receptor ligands.
|
J Nucl Med
|
2013
|
0.76
|
|
108
|
Sparing of the substantia nigra in sporadic Creutzfeldt-Jakob disease presenting as an acute corticobasal syndrome.
|
Mov Disord
|
2007
|
0.76
|
|
109
|
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.
|
EJNMMI Res
|
2013
|
0.75
|
|
110
|
Changes in functional integration with the non-epileptic temporal lobe of patients with unilateral mesiotemporal epilepsy.
|
PLoS One
|
2013
|
0.75
|
|
111
|
Highlights lecture EANM 2014: "Gimme gimme gimme those nuclear Super Troupers".
|
Eur J Nucl Med Mol Imaging
|
2015
|
0.75
|
|
112
|
New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation.
|
ACS Chem Neurosci
|
2013
|
0.75
|
|
113
|
In vivo amyloid imaging in cortical superficial siderosis.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.75
|
|
114
|
Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy.
|
Acta Neurol Belg
|
2006
|
0.75
|
|
115
|
Fluoro-D-glucose-micro positron emission tomography as a diagnostic tool to confirm brain death in a murine donor lung injury model.
|
J Surg Res
|
2012
|
0.75
|
|
116
|
Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction.
|
Psychiatry Res
|
2005
|
0.75
|
|
117
|
Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT.
|
Clin Nucl Med
|
2022
|
0.75
|
|
118
|
Lack of endogenous opioid release during sustained visceral pain: a [11C]carfentanil PET study.
|
Pain
|
2013
|
0.75
|
|
119
|
Chasing map plasticity in neuropathic pain.
|
World Neurosurg
|
2012
|
0.75
|
|
120
|
Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents.
|
J Med Chem
|
2009
|
0.75
|